| A significant increase in the frequency of hand-foot-mouth disease in İstanbul in June 2012 | Can BAYKAL, Algün EKİNCİ POLAT, Esma ERBUDAK | 192–193 |
| Use of cosmeceuticals during pregnancy and lactation period | Özlem ABUAF KARABUDAK, Hamza YILDIZ | 194–199 |
| Bullous disorders in Konya: A study of 93 cases | Musa DAYE, Sarenur ESENER, İnci MEVLİTOĞLU | 200–204 |
| Three-year observation of the patients with bullous pemphigoid: 29 cases | Özlem EKİZ, Emine Nur RİFAİOĞLU, Tuğba ŞEN, Asena DOĞRAMACI ÇİĞDEM, Bilge ŞEN BÜLBÜL | 205–208 |
| The clinical features, laboratory findings, treatment and follow-up results of patients with morphea | Aynur AKYOL, Bengü Nisa AKAY, Nehir PARLAK, Hatice ŞANLI ERDİ | 209–213 |
| Retrospectiveanalysisofmelanomapatientswho had undergone PET-CT examination | Sedef ŞAHİN, Tamer AKSOY, Erkan VARDARELİ, Özgür BAKAR, Selcen YÜKSEL | 214–217 |
| Evaluation of clinical features of 11 cases with DRESS syndrome | Ahmet METİN, Gülşen AKOĞLU, Selma EMRE, Düriye Deniz DEMİRSEREN, Gözde KURTOĞLU | 218–222 |
| Dermoscopicfindings in cicatricial alopecia | Gonca GÖKDEMİR, Seher ARI | 223–226 |
| Investigation of adenosine deaminase activity in patients with mycosis fungoides | Ayten FERAHBAŞ, Demet KARTAL, Cevat YAZICI, Yılmaz ULAŞ | 227–231 |
| Papulosquamous drug eruption and nail disorder due to Entekavir use | Hatice ÜNVERDİ, Ufuk ÖZUĞUZ, Elif ERARSLAN, Pınar ÖZUĞUZ | 232–235 |
| Recurrent toxin-mediated perinealerythema: A case report and literature review | Sema AYTEKİN | 236–238 |
| Clinical success with imiquimod alone and in combination with intralesional interferon in basal cell carcinoma | Hakan TURAN, Ayşegül TURAN, Emel BAŞKAN BÜLBÜL, Şaduman ADIM BALABAN, Sema ALGAN İPEK, Hayriye SARICAOĞLU | 239–241 |
| Monobenzylether of hydroquinone in universal vitiligo: A case report |